Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NRC
NRC logo

NRC Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
17.570
Open
17.210
VWAP
17.18
Vol
56.45K
Mkt Cap
390.33M
Low
16.820
Amount
969.91K
EV/EBITDA(TTM)
12.11
Total Shares
22.75M
EV
465.23M
EV/OCF(TTM)
17.59
P/S(TTM)
2.80
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.
Show More

Events Timeline

(ET)
2026-03-09
16:40:00
NRC Health Authorizes Stock Repurchase Program Up to $60M
select
2026-03-04 (ET)
2026-03-04
16:30:00
National Research Corporation TRCV Surpasses $152 Million
select
2025-08-28 (ET)
2025-08-28
08:06:11
Shane Harrison Named CFO of National Research Corporation
select
2025-07-28 (ET)
2025-07-28
17:02:27
National Research Corporation reports Q2 EPS (1c) vs. 26c last year
select
2025-03-04 (ET)
2025-03-04
16:06:35
National Research Corporation names Trent Green as new CEO
select
2025-01-07 (ET)
2025-01-07
11:02:11
NRC Health enters partnership with Renown Health
select

News

Newsfilter
7.5
03-19Newsfilter
Piedmont Healthcare Partners with NRC Health for Experience Management
  • Strategic Partnership: Piedmont Healthcare has partnered with NRC Health to enhance the overall experience for over 4.5 million patients served annually by integrating patient experience data and strengthening caregiver engagement, thereby driving mission-driven growth for the organization.
  • Patient Experience Enhancement: This collaboration will leverage NRC Health's Patient Experience, Leader Rounding, and Market Insights solutions to optimize the experiences of patients, families, and employees across 27 hospitals and 2,000 locations, further enhancing patient loyalty.
  • Community Impact: In Fiscal Year 2024, Piedmont provided over $607 million in community impact, demonstrating its strong presence and commitment to local communities, serving 85% of Georgia's population.
  • Industry Recognition: Piedmont has been recognized by Newsweek as one of America's Greatest Workplaces for Diversity in 2023 and 2024, and was listed by Forbes as one of the Best Large Employers in the United States in 2022, showcasing its excellence in employee satisfaction and diversity.
NASDAQ.COM
6.5
03-13NASDAQ.COM
Analyst Blog Highlights Featured Stocks Update
  • Oracle's Strong Earnings: Oracle's fiscal Q3 2026 results exceeded expectations with revenues and earnings, driven by an 84% surge in cloud infrastructure revenues, reflecting robust AI workload and multicloud demand, although the negative $13.2 billion free cash flow indicates ongoing investment pressures in data center expansions.
  • T-Mobile's Underperformance: T-Mobile's shares have declined 10.1% over the past six months, underperforming the industry average, primarily due to high debt and fierce competition; however, its leading postpaid customer growth and record-low churn rate provide a competitive edge, particularly with its 5G spectrum strategy.
  • Gilead's Sales Growth Outlook: Gilead's stock has risen 30.6% in the last six months, bolstered by its leading HIV portfolio, with expectations for approximately 6% growth in HIV sales in 2026, further supported by the approval of a long-acting injectable treatment that is expected to enhance revenue.
  • National Research's Rising Contract Value: National Research has seen its Total Recurring Contract Value rise to approximately $152 million over five consecutive quarters, despite revenue declines and competitive pressures, indicating potential for future revenue growth supported by its extensive presence in U.S. healthcare systems.
Benzinga
9.5
03-10Benzinga
U.S. Stocks Rise as NIO Reports Strong Earnings
  • Quarterly Revenue Surge: NIO reported quarterly revenue of 34.65 billion yuan ($4.95 billion), reflecting a year-over-year increase of 75.9% and a sequential rise of 59.0%, surpassing the analyst consensus estimate of $4.61 billion, indicating robust market demand and sales growth potential.
  • Significant Earnings Improvement: The company's adjusted earnings came in at 0.29 yuan (4 cents) per ADS, a remarkable turnaround from a loss of 3.17 yuan per ADS a year earlier, exceeding expectations for a 5-cent loss, showcasing effective cost control and enhanced profitability.
  • Stock Price Rally: Following the earnings report, NIO shares surged 10.6% to $5.47, reflecting investor optimism regarding the company's future growth prospects and potentially attracting more institutional investor interest.
  • Overall Market Performance: The U.S. stock market rose overall, with the Dow Jones index gaining around 200 points on Tuesday, indicating increased confidence in economic recovery, which may provide a favorable investment environment for NIO and other tech stocks.
seekingalpha
8.0
03-09seekingalpha
National Research Corporation Authorizes $60 Million Stock Repurchase Program
  • Repurchase Program Initiated: National Research Corporation (NRC) has authorized a stock repurchase program of up to $60 million, set to run through March 31, 2028, aimed at enhancing shareholder value and stabilizing stock prices.
  • Stock Price Reaction: Following the announcement, NRC's stock fell 1.94% in after-hours trading to $14.68, indicating a cautious initial market response to the repurchase plan.
  • Contract Value Growth: NRC's total recurring contract value has exceeded $152 million, demonstrating significant progress in stabilizing revenue sources, which supports future financial performance.
  • Market Environment Analysis: Amid increasing market volatility, NRC's repurchase plan not only reflects the company's confidence in its own value but may also attract more investor interest due to its potential for high dividend yields.
Newsfilter
8.0
03-09Newsfilter
NRC Health Authorizes $60 Million Stock Repurchase Program
  • Repurchase Program Initiation: NRC Health's Board of Directors has authorized a stock repurchase program of up to $60 million, set to run through March 31, 2028, aimed at enhancing shareholder value and boosting market confidence.
  • Flexible Repurchase Methods: The company plans to repurchase shares through various means, including open market and privately negotiated transactions, ensuring compliance with the Securities Exchange Act of 1934 to maintain transparency and legality in the process.
  • Market Condition Considerations: The timing, manner, price, and amount of repurchases will be determined at NRC Health's discretion, influenced by various factors such as market conditions and corporate financial health, ensuring the effectiveness and flexibility of the repurchase strategy.
  • Long-term Strategic Commitment: This repurchase program not only reflects NRC Health's confidence in future market performance but also demonstrates the company's strategic commitment to enhancing shareholder returns and maintaining market stability.
seekingalpha
9.5
03-04seekingalpha
National Research Exceeds $152 Million in Total Recurring Contract Value
  • Contract Value Growth: As of March 4, National Research Corporation's total recurring contract value (TRCV) surpassed $152 million, marking a 6% increase since the end of 2025 and a 13% year-over-year rise, indicating strong performance in renewable contracts that is expected to generate stable revenue over the next 12 months.
  • Financial Results Clarification: Despite the encouraging growth in TRCV, National Research emphasizes that this milestone does not represent its full financial results for the quarter ending March 31, 2026, reflecting a cautious approach to financial transparency that may influence short-term investor expectations.
  • Market Strategy Effectiveness: The company anticipates an 8% growth in TRCV into 2026, suggesting that its go-to-market strategy is gaining traction, which could lay the groundwork for future revenue growth and enhance its competitive position in the industry.
  • Stock Price Reaction: Following the announcement, National Research's stock price rose 0.15% in after-hours trading to $13.14 per share, reflecting market recognition of the company's future growth potential and possibly attracting more investor interest.

Valuation Metrics

The current forward P/E ratio for National Research Corp (NRC.O) is 0.00, compared to its 5-year average forward P/E of 28.96. For a more detailed relative valuation and DCF analysis to assess National Research Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
28.96
Current PE
0.00
Overvalued PE
39.59
Undervalued PE
18.32

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
19.06
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
25.65
Undervalued EV/EBITDA
12.47

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
6.39
Current PS
0.00
Overvalued PS
8.87
Undervalued PS
3.90

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

yes us stock
Intellectia · 49 candidates
Price: $10.00 - $150.00Relative Vol: >= 2List Exchange: XNYS, XNAS, XASEWeek Price Change Pct: >= $5.00Is Index Component: GSPC, RUT, DJI, NDXOne Day Rise Prob: >= 60
Ticker
Name
Market Cap$
top bottom
HCC logo
HCC
Warrior Met Coal Inc
4.24B
VERA logo
VERA
Vera Therapeutics Inc
2.87B
DAWN logo
DAWN
Day One Biopharmaceuticals Inc
2.20B
ANDE logo
ANDE
Andersons Inc
2.26B
KALV logo
KALV
Kalvista Pharmaceuticals Inc
932.07M
IPI logo
IPI
Intrepid Potash Inc
547.67M
what trades can I do within my budget
Intellectia · 43 candidates
Region: USPrice: $5.00 - $50.00Rsi Category: moderate, overboughtPrice Change Pct: $2.00 - $10.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SIRI logo
SIRI
Sirius XM Holdings Inc
7.69B
BYRN logo
BYRN
Byrna Technologies Inc
281.11M
RMR logo
RMR
RMR Group Inc
533.45M
ASX logo
ASX
ASE Technology Holding Co Ltd
43.15B
ORN logo
ORN
Orion Group Holdings Inc
545.05M
MCFT logo
MCFT
Mastercraft Boat Holdings Inc
395.64M

Whales Holding NRC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is National Research Corp (NRC) stock price today?

The current price of NRC is 17.16 USD — it has decreased -1.04

What is National Research Corp (NRC)'s business?

National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of four solution categories: Patient Experience, Consumer Experience, Employee Experience, and Market Experience, which can be implemented both collectively as an enterprise solution or individually to meet specific needs within the organization. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools. Its Reputation solutions allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs better consumer decision-making.

What is the price predicton of NRC Stock?

Wall Street analysts forecast NRC stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NRC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is National Research Corp (NRC)'s revenue for the last quarter?

National Research Corp revenue for the last quarter amounts to 35.19M USD, decreased -4.64

What is National Research Corp (NRC)'s earnings per share (EPS) for the last quarter?

National Research Corp. EPS for the last quarter amounts to 0.07 USD, decreased -75.00

How many employees does National Research Corp (NRC). have?

National Research Corp (NRC) has 357 emplpoyees as of April 06 2026.

What is National Research Corp (NRC) market cap?

Today NRC has the market capitalization of 390.33M USD.